Melanoma Information Center
Each year in the United States, more than 62,000 people are diagnosed with melanoma. There are an estimated 723,000 melanoma survivors living in the United States today. Exposure to ultraviolet radiation increases the risk of melanoma, and sun protection plays an important role in melanoma prevention. Once melanoma occurs, it is important to detect and treat it as early as possible in order to obtain the best outcomes.
Early-stage melanoma may be treated with surgery alone, but treatment of more advanced disease remains challenging. Researchers are continuing to explore new approaches to treatment in clinical trials. Advances are also being made in supportive care; high-quality supportive care makes melanoma treatment more tolerable and improves quality of life.
Understanding melanoma treatment options, the role of different doctors specializing in the treatment of melanoma, and how and when to access new and innovative melanoma treatment options available through clinical trials is essential in order to achieve the best outcome from melanoma treatment.
The Cancer Consultants Melanoma Information Center has been designed to help patients understand options for melanoma prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of melanoma.
Headline Melanoma News 
Advances in Melanoma Treatment and Research
After almost 20 years, new treatments emerge. By Mia James Melanoma is considered...
Melanoma Drug Accelerates Secondary Skin Cancers In Some Patients
Finding may lead to improved approaches to treatment.
Melanoma More Common in Cancer Survivors
Risk particularly high for those with a prior diagnosis of melanoma.
Melanoma Tips
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Melanoma Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Melanoma Clinical Trials
VicalLX01-315-02 – A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7 Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma
COGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN 2b in Stage T3-T4 or N1 (microscopic) Melanoma
ECOGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-2, N1a, 2a (microscopic) Melanoma.
 |
 |
 |
 |
